Protarga is a clinical stage pharmaceutical company that is developing Targaceutical® drugs for new medical therapies. The Company's strategic priority is the development of innovative new treatments for cancer, infectious diseases, and CNS disorders.
| Website | http://www.protarga.com |
| Revenue | $8.8 million |
| Employees | View employees |
| Address | 264 Welsh Pool Rd, Exton, Pennsylvania 19341, US |
| Industry | Internet Service Providers, Website Hosting & Internet-Related Services, Telecommunications |
| Competitors | Regeneron, Vertex Pharmaceuticals, Moderna Therapeutics, Alnylam Pharmaceuticals, Emergent BioSolutions, Novavax, CureVac, Sangamo Therapeutics, Inc., Zymergen, Inc. +39 more (view full list) |
| SIC | SIC Code 58 Companies, SIC Code 581 Companies, SIC Code 2834 Companies, SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 722 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 72 Companies |
Looking for a particular Protarga , Inc. employee's phone or email?
Protarga , Inc. Questions
The Protarga , Inc. annual revenue was $8.8 million in 2026.
Protarga , Inc. is based in Exton, Pennsylvania.
The NAICS codes for Protarga , Inc. are [722, 325, 32541, 3254, 32, 72].
The SIC codes for Protarga , Inc. are [58, 581, 2834, 283, 28].
G2Crowd Trusted
300K+
Plugin Users
